Figure 4.
Statin therapy in individuals with self-reported hypercholesterolemia. Fasting LDL targets are according to the Adult Treatment Panel III cholesterol recommendations. Using the Framingham risk score, individuals at low risk have 10% or less CHD risk at 10 years, individuals at intermediate risk have 10%–20% CHD risk at 10 years, and individuals at high risk have 20% or more CHD risk at 10 years. Individuals on target used a statin significantly more often (P<0.001).